This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Clopidogrel

Read time: 1 mins
Marketing start date: 27 Apr 2024

Summary of product characteristics


Effective Time

20231003

Version

7

Spl Product Data Elements

clopidogrel clopidogrel CLOPIDOGREL BISULFATE CLOPIDOGREL ANHYDROUS LACTOSE CITRIC ACID MONOHYDRATE CROSPOVIDONE (15 MPA.S AT 5%) FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE HYDROXYPROPYL CELLULOSE (1600000 WAMW) HYPROMELLOSES LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SILICON DIOXIDE HYDROGENATED CASTOR OIL TITANIUM DIOXIDE FERRIC OXIDE RED STARCH, CORN PINK ROUND 379

Application Number

ANDA201686

Brand Name

Clopidogrel

Generic Name

clopidogrel

Product Ndc

70771-1062

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1062-9 in bottle of 90 Tablets Clopidogrel Tablets USP, 75 mg Rx only 90 TABLETS Clopidogrel Tablets, 75 mg

Spl Medguide

Manufactured by: Cadila Healthcare Ltd. India.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.